Baxter International Inc.
BAXLast close · Oct 16, 202625.28−0.48 (−1.86%)
Market cap$13.1B
Between Feb 9, 2026 and Sep 2, 2026, Baxter International (BAX) insiders filed 40 Form 4 transactions: no sale and no open-market purchase. 40 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
0
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Teaff James | President, CCS | F | 750 | 25.48 | $19,110 | |
| 2026-09-02 | Hider Andrew P. | President and CEO | F | 54,276 | 25.70 | $1.4M | |
| 2026-09-02 | Foster Julie | President, Front Line Care | F | 2,098 | 25.70 | $53,918.6 | |
| 2026-06-01 | Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | A | 13,426 | 0.00 | $0 | |
| 2026-06-02 | Wallace Steven P. | President, Adv. Surgery | F | 153 | 18.68 | $2,858 | |
| 2026-06-02 | Teaff James | President, CCS | F | 321 | 18.68 | $5,996.3 | |
| 2026-05-05 | Wilkes David S. | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | Wendell Amy McBride | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | SCHLICHTING NANCY M | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | MORRISON PATRICIA | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | Shafer David Brent | Director, Other | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | McDonnell Michael R. | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | Craig Jeffrey A | Director | A | 12,836 | 0.00 | $0 | |
| 2026-05-05 | Ampofo William A. II | Director | A | 12,836 | 0.00 | $0 | |
| 2026-03-06 | Zielinski Anita A | SVP, CAO and Controller | F | 1,932 | 17.69 | $34,177.1 | |
| 2026-03-06 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | 2,848 | 17.69 | $50,381.1 | |
| 2026-03-06 | Rosenbloom David S. | EVP and General Counsel | F | 6,620 | 17.69 | $117,107.8 | |
| 2026-03-06 | Rasul Reazur | EVP,Group Pres,Healthcare | F | 12,674 | 17.69 | $224,203.1 | |
| 2026-03-06 | Grade Joel T. | EVP and CFO | F | 8,153 | 17.69 | $144,226.6 | |
| 2026-02-27 | Hider Andrew P. | President and CEO | A | 201,804 | 0.00 | $0 | |
| 2026-02-27 | Hider Andrew P. | President and CEO | A | 488,506 | 0.00 | $0 | |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | A | 17,806 | 0.00 | $0 | |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | A | 11,871 | 0.00 | $0 | |
| 2026-02-27 | Carlisle Cynthia | Executive Vice President, CHRO | A | 43,103 | 0.00 | $0 | |
| 2026-03-02 | Rasul Reazur | EVP,Group Pres,Healthcare | F | 1,614 | 19.69 | $31,779.7 | |
| 2026-02-27 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | 23,742 | 0.00 | $0 | |
| 2026-03-02 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | 1,852 | 19.69 | $36,465.9 | |
| 2026-02-27 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | 57,471 | 0.00 | $0 | |
| 2026-02-27 | Rosenbloom David S. | EVP and General Counsel | A | 26,709 | 0.00 | $0 | |
| 2026-03-02 | Rosenbloom David S. | EVP and General Counsel | F | 1,336 | 19.69 | $26,305.8 | |
| 2026-02-27 | Rosenbloom David S. | EVP and General Counsel | A | 64,655 | 0.00 | $0 | |
| 2026-02-27 | Grade Joel T. | EVP and CFO | A | 42,735 | 0.00 | $0 | |
| 2026-02-27 | Grade Joel T. | EVP and CFO | A | 103,448 | 0.00 | $0 | |
| 2026-02-27 | Zielinski Anita A | SVP, CAO and Controller | A | 30,864 | 0.00 | $0 | |
| 2026-02-13 | McDonnell Michael R. | Director | A | 1,811 | 0.00 | $0 | |
| 2026-02-09 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | A | 2,273 | 0.00 | $0 | |
| 2026-02-09 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | F | 918 | 21.73 | $19,948.1 | |
| 2026-02-09 | Rosenbloom David S. | EVP and General Counsel | A | 17,055 | 0.00 | $0 | |
| 2026-02-09 | Rosenbloom David S. | EVP and General Counsel | F | 5,225 | 21.73 | $113,539.3 | |
| 2026-02-09 | Rasul Reazur | EVP,Group Pres,Healthcare | A | 18,951 | 0.00 | $0 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.